CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
27.83
1.17%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.11
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Rxsight Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 28.16
Open* 28.33
1-Year Change* 147.42%
Day's Range* 27.66 - 28.43
52 wk Range 9.78-33.77
Average Volume (10 days) 436.66K
Average Volume (3 months) 10.02M
Market Cap 1.06B
P/E Ratio -100.00K
Shares Outstanding 35.64M
Revenue 67.00M
EPS -1.94
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Nov 6, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 29, 2023 27.83 -1.02 -3.54% 28.85 28.85 27.60
Sep 28, 2023 28.16 0.63 2.29% 27.53 28.45 27.46
Sep 27, 2023 27.51 0.51 1.89% 27.00 27.63 26.93
Sep 26, 2023 27.21 0.35 1.30% 26.86 27.56 26.86
Sep 25, 2023 26.98 0.01 0.04% 26.97 27.36 26.86
Sep 22, 2023 27.17 0.20 0.74% 26.97 28.19 26.76
Sep 21, 2023 27.36 -0.35 -1.26% 27.71 27.75 26.46
Sep 20, 2023 28.30 0.15 0.53% 28.15 28.76 27.71
Sep 19, 2023 28.33 0.77 2.79% 27.56 28.77 27.48
Sep 18, 2023 28.19 -1.53 -5.15% 29.72 29.79 28.12
Sep 15, 2023 29.77 0.01 0.03% 29.76 29.88 29.44
Sep 14, 2023 29.62 0.06 0.20% 29.56 29.64 28.77
Sep 13, 2023 29.55 2.14 7.81% 27.41 29.84 27.22
Sep 12, 2023 27.64 -1.82 -6.18% 29.46 29.86 27.54
Sep 11, 2023 30.12 1.08 3.72% 29.04 30.39 28.82
Sep 8, 2023 28.94 -0.63 -2.13% 29.57 30.60 28.77
Sep 7, 2023 29.65 0.27 0.92% 29.38 30.46 28.96
Sep 6, 2023 29.45 1.23 4.36% 28.22 29.48 28.22
Sep 5, 2023 28.43 -0.54 -1.86% 28.97 28.97 28.18
Sep 1, 2023 29.12 0.66 2.32% 28.46 29.45 28.46

RxSight, Inc. Events

Time (UTC) Country Event
Monday, November 6, 2023

Time (UTC)

10:59

Country

US

Event

Q3 2023 Rxsight Inc Earnings Release
Q3 2023 Rxsight Inc Earnings Release

Forecast

-

Previous

-
Monday, March 4, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 Rxsight Inc Earnings Release
Q4 2023 Rxsight Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019
Total revenue 49.005 22.593 14.678 2.241
Revenue 49.005 22.593 14.678 2.241
Cost of Revenue, Total 27.677 18.076 12.973 4.06
Gross Profit 21.328 4.517 1.705 -1.819
Total Operating Expense 112.323 75.38 50.09 48.311
Selling/General/Admin. Expenses, Total 58.961 33.077 15.132 15.178
Research & Development 25.657 24.202 21.819 29.42
Depreciation / Amortization 0.028 0.025 0.159 0.174
Unusual Expense (Income) 0 0.007 -0.521
Operating Income -63.318 -52.787 -35.412 -46.07
Interest Income (Expense), Net Non-Operating -3.429 -3.628 0.033 2.281
Other, Net 0 7.735 63.011 170.033
Net Income Before Taxes -66.747 -48.68 27.632 126.244
Net Income After Taxes -66.756 -48.688 27.575 126.22
Net Income Before Extra. Items -66.756 -48.688 27.575 126.22
Net Income -66.756 -48.688 27.575 126.22
Total Adjustments to Net Income 0 -24.209 -100.093
Income Available to Common Excl. Extra. Items -66.756 -48.688 3.366 26.127
Income Available to Common Incl. Extra. Items -66.756 -48.688 3.366 26.127
Diluted Net Income -66.756 -48.688 3.366 26.127
Diluted Weighted Average Shares 28.2684 27.3668 26.295 26.295
Diluted EPS Excluding Extraordinary Items -2.36151 -1.77909 0.12801 0.99361
Diluted Normalized EPS -2.36151 -1.77909 0.12827 0.9738
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 20.81 17.489 16.088 12.615 11.36
Revenue 20.81 17.489 16.088 12.615 11.36
Cost of Revenue, Total 8.795 7.123 8.666 7.259 6.572
Gross Profit 12.015 10.366 7.422 5.356 4.788
Total Operating Expense 34.797 30.586 31.078 28.573 27.152
Selling/General/Admin. Expenses, Total 18.254 16.283 15.803 15 14.469
Research & Development 7.348 7.137 6.599 6.275 6.075
Depreciation / Amortization 0.038 0.043 0.01 0.039 0.036
Operating Income -13.987 -13.097 -14.99 -15.958 -15.792
Interest Income (Expense), Net Non-Operating 0.209 -0.115 -0.615 -0.86 -0.94
Other, Net 0 0 0
Net Income Before Taxes -13.778 -13.212 -15.605 -16.818 -16.732
Net Income After Taxes -13.804 -13.212 -15.61 -16.818 -16.732
Net Income Before Extra. Items -13.804 -13.212 -15.61 -16.818 -16.732
Net Income -13.804 -13.212 -15.61 -16.818 -16.732
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items -13.804 -13.212 -15.61 -16.818 -16.732
Income Available to Common Incl. Extra. Items -13.804 -13.212 -15.61 -16.818 -16.732
Diluted Net Income -13.804 -13.212 -15.61 -16.818 -16.732
Diluted Weighted Average Shares 34.4983 31.6371 30.4196 27.6658 27.5599
Diluted EPS Excluding Extraordinary Items -0.40014 -0.41761 -0.51316 -0.6079 -0.60711
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.39332 -0.41761 -0.51316 -0.6079 -0.60711
Unusual Expense (Income) 0.362
  • Annual
  • Quarterly
2022 2021 2020 2019
Total Current Assets 134.555 176.295 81.5 90.199
Cash and Short Term Investments 105.802 159.332 68.975 80.668
Cash & Equivalents 11.834 24.361 13.994 7.958
Short Term Investments 93.968 134.971 54.981 72.71
Total Receivables, Net 10.956 4.862 2.865 0.789
Accounts Receivable - Trade, Net 10.956 4.862 2.865 0.789
Total Inventory 14.835 8.032 8.288 7.219
Prepaid Expenses 2.962 4.069 1.372 1.523
Total Assets 150.164 192.721 100.677 110.432
Property/Plant/Equipment, Total - Net 14.081 15.501 18.606 19.25
Property/Plant/Equipment, Total - Gross 33.979 31.846 30.979 27.789
Accumulated Depreciation, Total -19.898 -16.345 -12.373 -8.539
Other Long Term Assets, Total 1.528 0.925 0.571 0.983
Total Current Liabilities 17.237 11.077 11.6 8.457
Accounts Payable 2.595 1.689 1.134 2.199
Accrued Expenses 10.81 8.615 4.935 5.715
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.152 0.02 0.027 0.129
Other Current Liabilities, Total 3.68 0.753 5.504 0.414
Total Liabilities 60.262 54.479 44.906 87.462
Total Long Term Debt 40.212 39.777 24.436 0.054
Long Term Debt 40.169 39.76 24.399 0
Capital Lease Obligations 0.043 0.017 0.037 0.054
Other Liabilities, Total 2.813 3.625 8.87 78.951
Total Equity 89.902 138.242 55.771 22.97
Redeemable Preferred Stock 0 353.3 327.581
Common Stock 0.028 0.027 80.78 56.422
Retained Earnings (Accumulated Deficit) -546.032 -479.276 -377.503 -360.224
Other Equity, Total -0.095 -0.02 -0.806 -0.809
Total Liabilities & Shareholders’ Equity 150.164 192.721 100.677 110.432
Total Common Shares Outstanding 28.2684 27.3668 26.295 26.295
Additional Paid-In Capital 636.001 617.511
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 187.666 134.555 139.162 149.928 161.147
Cash and Short Term Investments 153.939 105.802 112.835 128.62 143.847
Cash & Equivalents 11.012 11.834 8.912 24.004 24.132
Short Term Investments 142.927 93.968 103.923 104.616 119.715
Total Receivables, Net 12.668 10.956 9.02 6.884 5.626
Accounts Receivable - Trade, Net 12.668 10.956 9.02 6.884 5.626
Total Inventory 18.067 14.835 15.336 11.622 8.49
Prepaid Expenses 2.992 2.962 1.971 2.802 3.184
Total Assets 202.532 150.164 155.706 166.714 177.062
Property/Plant/Equipment, Total - Net 13.359 14.081 14.951 15.787 14.972
Other Long Term Assets, Total 1.507 1.528 1.593 0.999 0.943
Total Current Liabilities 14.876 17.237 16.368 12.996 10.659
Accounts Payable 3.717 2.595 4.172 3.277 2.587
Accrued Expenses 11.045 14.49 12.036 9.593 7.997
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.114 0.152 0.16 0.126 0.075
Other Current Liabilities, Total
Total Liabilities 57.523 60.262 59.747 56.728 53.899
Total Long Term Debt 40.309 40.212 40.099 39.988 39.974
Long Term Debt 40.309 40.169 40.025 39.881 39.89
Capital Lease Obligations 0 0.043 0.074 0.107 0.084
Other Liabilities, Total 2.338 2.813 3.28 3.744 3.266
Total Equity 145.009 89.902 95.959 109.986 123.163
Redeemable Preferred Stock
Common Stock 0.034 0.028 0.028 0.027 0.027
Additional Paid-In Capital 704.228 636.001 626.491 623.746 620.106
Retained Earnings (Accumulated Deficit) -559.244 -546.032 -530.422 -513.604 -496.872
Other Equity, Total -0.009 -0.095 -0.138 -0.183 -0.098
Total Liabilities & Shareholders’ Equity 202.532 150.164 155.706 166.714 177.062
Total Common Shares Outstanding 33.9667 28.2684 27.7191 27.6315 27.4857
  • Annual
  • Quarterly
2022 2021 2020 2019
Net income/Starting Line -66.756 -48.688 27.575 126.22
Cash From Operating Activities -58.85 -44.708 -35.203 -40.619
Cash From Operating Activities 4.022 3.988 4.012 3.93
Non-Cash Items 11.296 2.67 -58.942 -166.798
Cash Taxes Paid 0.003 0.02 0.061 0.019
Cash Interest Paid 4.257 3.187 0.425 0.026
Changes in Working Capital -7.412 -2.678 -7.848 -3.971
Cash From Investing Activities 39.95 -81.907 15.591 -5.87
Capital Expenditures -2.393 -1.94 -2.539 -4.086
Other Investing Cash Flow Items, Total 42.343 -79.967 18.13 -1.784
Cash From Financing Activities 6.332 137.342 25.237 1.33
Financing Cash Flow Items -1.375 -0.132 -0.687 0
Issuance (Retirement) of Stock, Net 7.828 122.501 1.066 1.515
Issuance (Retirement) of Debt, Net -0.121 14.973 24.858 -0.185
Foreign Exchange Effects -0.009 -0.01 0.005
Net Change in Cash -12.577 10.717 5.625 -45.154
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -13.212 -66.756 -51.146 -34.328 -17.596
Cash From Operating Activities -17.764 -58.85 -44.996 -29.808 -14.985
Cash From Operating Activities 0.999 4.022 3.061 2.081 1.035
Non-Cash Items 2.189 11.296 8.675 5.707 2.805
Cash Taxes Paid 0 0.003 0.003 0.003 0
Cash Interest Paid 1.348 4.257 3.037 1.907 0.928
Changes in Working Capital -7.74 -7.412 -5.586 -3.268 -1.229
Cash From Investing Activities -48.365 39.95 29.545 28.985 14.859
Capital Expenditures -0.747 -2.393 -2.031 -1.451 -0.37
Other Investing Cash Flow Items, Total -47.618 42.343 31.576 30.436 15.229
Cash From Financing Activities 65.305 6.332 0.025 0.48 -0.098
Financing Cash Flow Items -0.567 -1.375 -1.082 -0.504 -0.362
Issuance (Retirement) of Stock, Net 65.913 7.828 1.189 1.044 0.308
Issuance (Retirement) of Debt, Net -0.041 -0.121 -0.082 -0.06 -0.044
Foreign Exchange Effects 0.002 -0.009 -0.023 -0.014 -0.005
Net Change in Cash -0.822 -12.577 -15.449 -0.357 -0.229

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

RxSight, Inc. Company profile

About Rxsight Inc

RxSight, Inc. is a commercial-stage medical technology company. The Company is engaged in improving the vision of patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system), comprised of its RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Its LAL is made of photosensitive material that changes shape in response to patterns of ultraviolet (UV) light generated by its LDD. Its RxSight system helps surgeon to performs a standard cataract procedure to implant the LAL, and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes. Alternative IOL technologies, are not adjustable following the surgery and therefore require patients to make pre-operative choices about their visual preferences.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Rxsight Inc revenues increased 54% to $22.6M. Net loss applicable to common stockholders totaled $48.7M vs. income of $3.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Change in fair value of warrants decrease of 96% to $2.7M (income), Selling, general and administrative - B increase from $15.1M to $31.2M

Industry: Medical Equipment, Supplies & Distribution (NEC)

100 Columbia Street
Suite 120
ALISO VIEJO
CALIFORNIA 92656
US

Income Statement

  • Annual
  • Quarterly

News

How to Trade The Triple Top

Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

14:13, 27 September 2023
USA flag on the background of stock charts. Financial system in USA

Q4 lookahead: US indices starting to show signs of trouble?

US indices start to draw attention as traders focus on the outlook for Q4.

07:20, 27 September 2023

USD/JPY Climbs Towards Key Highs

USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

11:32, 26 September 2023

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

People also watch

US100

14,744.20 Price
+0.120% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 7.0

XRP/USD

0.52 Price
-0.090% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

BTC/USD

27,152.15 Price
+0.140% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

ETH/USD

1,680.23 Price
-0.170% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading